Health service research
Citations 41-50 of 6773 total displayed.
Past content
(since Apr 1841):
|
-
- News
- Questions hang over European patent for hepatitis C drug after ruling
- Ned Stafford
-
BMJ 2016;355:i5493, doi: 10.1136/bmj.i5493,
-
[Extract]
[Full text]
[PDF]
-
- News
- Trump and Clinton clash over Obamacare in second presidential debate
- Jeanne Lenzer
-
BMJ 2016;355:i5495, doi: 10.1136/bmj.i5495,
-
[Extract]
[Full text]
[PDF]
-
- News
- US blood testing company cuts workforce by 40%
- Michael McCarthy
-
BMJ 2016;355:i5474, doi: 10.1136/bmj.i5474,
-
[Extract]
[Full text]
[PDF]
-
- Editor's choice
- How should doctors be employed?
- Fiona Godlee
-
BMJ 2016;355:i5394, doi: 10.1136/bmj.i5394,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- The end of Down’s syndrome?
- Jacqui Wise
-
BMJ 2016;355:i5344, doi: 10.1136/bmj.i5344,
-
[Extract]
[Full text]
[PDF]
-
- News
- NICE recommends first drug through "managed access" model of the Cancer Drugs Fund
- Susan Mayor
-
BMJ 2016;355:i5398, doi: 10.1136/bmj.i5398,
-
[Extract]
[Full text]
[PDF]
-
- News
- Hunt aims for fully home grown doctor workforce
- Ingrid Torjesen
-
BMJ 2016;355:i5399, doi: 10.1136/bmj.i5399,
-
[Extract]
[Full text]
[PDF]
-
- RESEARCH NEWS
- Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows
- Ingrid Torjesen
-
BMJ 2016;355:i5362, doi: 10.1136/bmj.i5362,
-
[Full text]
[PDF]
-
- News
- Muscular dystrophy drug looks set for commercial success despite clinical doubts
- Owen Dyer
-
BMJ 2016;355:i5346, doi: 10.1136/bmj.i5346,
-
[Extract]
[Full text]
[PDF]
-
- News
- Clinton promises to expand healthcare access and cut out-of-pocket costs
- Michael McCarthy
-
BMJ 2016;354:i5328, doi: 10.1136/bmj.i5328,
-
[Extract]
[Full text]
[PDF]
|